Rocket Lab Surges Into Focus as SpaceX Prices Tonight

Analyst Targets

• Citizens JMP – Buy | PT: $95 (raised from $85)
• Cantor Fitzgerald – Overweight | PT: $96 (raised from $85)
• Goldman Sachs – Neutral | PT: $76 (raised from $73)
• Clear Street – Buy | PT: $129 (raised from $98)
• Wells Fargo – Hold | PT: undisclosed
• Consensus (15 analysts) – Buy | Avg PT: ~$105 | Range: $60 – $150

The most important IPO in a generation prices tonight.

SpaceX sets its final offer price after market close today – $135 per share, implying a $1.75 trillion valuation – before its Nasdaq debut tomorrow, June 12, under ticker SPCX. That single event is pulling capital attention across every publicly traded space name. And Rocket Lab USA ($RKLB) is sitting right in the middle of it.

It’s not hard to see why. When institutional investors want to map peer valuations ahead of the largest IPO in market history, RKLB is the most liquid, most comparable public benchmark in the sector. That dynamic has driven the stock up more than 400% over the past year, and roughly 85% year-to-date – a run that says as much about sector sentiment as it does about Rocket Lab’s underlying business.

Worth noting: RKLB closed at $105.05 yesterday and is seeing pre-market movement this morning. The valuation debate is live and active among analysts, with targets spanning from $60 to $150 – a spread that signals genuine disagreement about how much of the space economy’s future is already in the price.

Company Profile

Founded by Sir Peter Beck in 2006 and headquartered in Long Beach, California, Rocket Lab operates across two core segments: Launch Services and Space Systems. Launch Services centers on the Electron rocket – the workhorse of small satellite deployment – plus the hypersonic HASTE vehicle. Space Systems covers spacecraft design, satellite components, manufacturing, and on-orbit management.

The company recently completed the acquisition of Mynaric AG for approximately $160 million (April 2026), adding laser communications hardware to its stack, and closed the acquisition of Motiv Space Systems in May 2026, now rebranded as Rocket Lab Robotics. The vertically integrated model is expanding fast. Neutron – the larger medium-lift rocket targeting both commercial and national security payloads – remains on track for its first launch in late 2026.

The Numbers – Q1 2026

• Revenue: $200.3M vs. ~$189.4M consensus estimate (+63.5% YoY) – first time above $200M in a single quarter
• Space Systems: $136.7M vs. $132.1M estimate (+57.2% YoY)
• Launch Services: $63.7M vs. $59.0M estimate (+78.9% YoY)
• GAAP Gross Margin: 38.2% | Non-GAAP Gross Margin: 43%
• GAAP Net Loss: $45.0M (narrowed from $60.6M a year ago)
• Adjusted EBITDA Loss: $11.8M vs. $25.1M expected – a significant beat
• Backlog: $2.2B (+20.2% sequentially, +108% YoY)
• New Contracts Signed: 31 Electron/HASTE contracts in Q1 alone – more than all of 2025
• Neutron Agreements: 5 new dedicated launch contracts; total manifest now 70+ missions
• Q2 2026 Guidance: $225M – $240M revenue (vs. $207.5M LSEG estimate)

Why the Stock Is Moving

Two forces are converging. First, Rocket Lab’s own fundamentals are genuinely strong. Q1 revenue came in above the high end of the company’s own guidance range. Margins are improving. The backlog more than doubled year-over-year. The EBITDA loss came in roughly half of what analysts expected. That Q1 report alone sent the stock up 34% in a single session in May – its best day ever.

Second, and perhaps more dominant right now: the SpaceX IPO effect. As institutional capital maps what a $1.75 trillion SpaceX valuation implies for the broader space economy, RKLB is the most direct comparable available in public markets. That peer-valuation exercise is pulling real capital into the name.

The slight tangent that matters here: SpaceX’s own financials are more complex than the IPO hype suggests. The company posted a GAAP net loss of $4.94 billion for full-year 2025, with Q1 2026 adding another $4.28 billion in losses – driven heavily by xAI integration costs. Starlink remains the profit center, generating an estimated $11.3 billion in 2025 revenue. At 94x revenue, SPCX is being valued on future execution, not current earnings. That context matters for how investors think about RKLB’s own stretched multiples.

Macro and Industry Context

Demand for space infrastructure is accelerating from multiple directions. President Trump’s Golden Dome missile defense initiative is expanding defense contract opportunities across the sector. NASA’s Artemis program continues to build a commercial supply chain. And the Pentagon’s Space Development Agency (SDA) Tranche II and III satellite programs – both of which Rocket Lab is already contracted on – represent multi-year government revenue floors that most commercial space companies can only aspire to.

The SpaceX IPO itself, priced at $135 per share with 30% of the float earmarked for retail investors, has attracted more than $250 billion in investor demand against a $75 billion raise – roughly 3.5x oversubscribed as of this week. That level of capital attention doesn’t stay contained. It bleeds into every public name adjacent to the sector.

Forward Scenarios

• Bull Case: SpaceX’s Nasdaq debut drives sustained capital rotation into public space names. Neutron launches successfully in late 2026. Defense contracts expand. RKLB re-rates toward the $129 – $150 range as institutional coverage expands. Q2 guidance of $225M – $240M is met or exceeded.
• Base Case: RKLB holds near current levels with elevated volatility. SpaceX IPO creates short-term noise but doesn’t materially change RKLB’s fundamental trajectory. Neutron remains on schedule but pre-revenue. Stock trades within a wide $90 – $120 band through year-end.
• Bear Case: SpaceX IPO unlocks direct institutional access to the leading space operator, pulling capital out of RKLB proxies. Neutron faces delays. The EV/Sales multiple – currently near 96x – compresses sharply as rate sensitivity returns. Stock pulls back toward the $60 – $76 range supported by Goldman Sachs and Wells Fargo targets.

Technical Overlay

RKLB broke and held above $100 for the first time following the Q1 earnings reaction in early May. That level is now a psychological support zone. The stock has since pulled back modestly – closing at $105.05 yesterday after a 4.85% decline on June 9, suggesting some near-term caution from options traders. Pre-market movement this morning reflects renewed interest tied to SpaceX’s pricing event tonight.

Key levels to watch: $100 as near-term support, $129 as the current street-high target from Clear Street. A sustained move above $110 with volume would shift momentum back to the upside. A break below $95 reopens the conversation about valuation compression.

What Investors Should Watch

• SpaceX (SPCX) opening trade behavior on Nasdaq June 12 – does capital flow toward or away from RKLB?
• Q2 2026 earnings – guidance of $225M – $240M sets a high bar; execution here is critical for multiple sustainability
• Neutron development milestones – any schedule change moves the stock materially
• Defense contract pipeline – Golden Dome and SDA awards are the near-term revenue levers
• Analyst revisions post-SpaceX listing – Goldman and Wells Fargo are the holdouts; upgrades from neutral-rated firms would be significant
• Insider activity – CFO Adam Spice has filed intent to sell 63,000 shares; worth monitoring

Bottom Line

Rocket Lab’s fundamentals are legitimately strong. Record revenue. Expanding backlog. Improving margins. A defense contract pipeline that most pure-play space companies can’t match. The Q1 report left very little to criticize operationally.

What’s less clear is whether the current valuation – north of 85x trailing revenue – reflects that strength or simply reflects the gravitational pull of the SpaceX IPO cycle. Both things can be true at once: the business is executing well, and the stock is partially priced on momentum rather than near-term fundamentals.

The real question isn’t whether RKLB deserves to be in the conversation. It does. The question is what happens to that conversation the morning after SPCX starts trading and institutional investors have direct access to the category leader for the first time. That’s what tomorrow actually decides.

For informational purposes only.